Contractor
CHARTWELL RX LLC
- UEI
- ER5UA9TYBGH4
- Parent UEI
- ER5UA9TYBGH4
- Resolved by
- uei
- Confidence
- 1.000
Active from Feb 27, 2026 to Jul 7, 2026.
Recent awards
| Award | Agency | Place | First action | Current value |
|---|---|---|---|---|
| 36F79720D0198 UPDATE ESTIMATED VALUE | Department of Veterans Affairs | — | Jul 7, 2026 | — |
| SPE2D326F093F 4571726909!DOXYCYCLINE HYCLATE 100 MG TAB 1000S | Department of Defense | NY | May 5, 2026 | $292 |
| SPE2D326F089Q 4571705930!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | May 4, 2026 | $330 |
| SPE2D326F090G 4571705931!DOXYCYCLINE HYCLATE 100 MG TAB 1000S | Department of Defense | NY | May 4, 2026 | $175 |
| SPE2D326F089H 4571705933!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | May 4, 2026 | $330 |
| SPE2D326F084Z 4571686322!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | May 1, 2026 | $1,322 |
| SPE2D326F070Z 4571655693!DOXYCYCLINE HYCLATE 100 MG TAB 1000S | Department of Defense | NY | Apr 29, 2026 | $175 |
| SPE2D326F070R 4571655694!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | Apr 29, 2026 | $330 |
| SPE2D326F072P 4571663729!ONDANSETRON ODT 8 MG TABLET 30S | Department of Defense | NY | Apr 29, 2026 | $367 |
| SPE2D326F072X 4571663728!ONDANSETRON ODT 8 MG TABLET 30S | Department of Defense | NY | Apr 29, 2026 | $184 |
| SPE2D326F068Q 4571642771!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | Apr 28, 2026 | $881 |
| SPE2D326F058U 4571606073!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | Apr 24, 2026 | $220 |
| SPE2D326F056V 4571590797!ONDANSETRON ODT 8 MG TABLET 30S | Department of Defense | NY | Apr 23, 2026 | $8,258 |
| SPE2D326F050E 4571574859!ONDANSETRON ODT 8 MG TABLET 30S | Department of Defense | NY | Apr 22, 2026 | $1,835 |
| SPE2D326F041X 4571559122!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | Apr 21, 2026 | $551 |
| SPE2D326F039C 4571542451!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | Apr 20, 2026 | $661 |
| SPE2D326F038J 4571542450!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | Apr 20, 2026 | $220 |
| SPE2D326F035K 4571520013!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | Apr 17, 2026 | $551 |
| SPE2D326F030T 4571519604!ONDANSETRON ODT 8 MG TABLET 30S | Department of Defense | NY | Apr 16, 2026 | $2,202 |
| SPE2D326F030M 4571519605!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | Apr 16, 2026 | $1,432 |
| SPE2D326F024R 4571489763!TERBINAFINE HCL 250 MG TABLET 30S | Department of Defense | NY | Apr 14, 2026 | $120 |
| SPE2D326F014B 4571457300!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | Apr 13, 2026 | $110 |
| SPE2D326F011N 4571439361!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | Apr 10, 2026 | $441 |
| SPE2D326F009R 4571448453!ONDANSETRON ODT 4 MG TABLET 30S | Department of Defense | NY | Apr 9, 2026 | $220 |
| SPE2D326F9944 4571407712!ONDANSETRON ODT 8 MG TABLET 30S | Department of Defense | NY | Apr 8, 2026 | $367 |
Sources and method
Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.
Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.
- 1Awards are attributed by Unique Entity Identifier ER5UA9TYBGH4, the government's own recipient identifier, not by name matching.
- 2Award records from USAspending.gov, last refreshed Aug 10, 2026.